Nu Skin Enterprises (NUS) Stock Price, News & Analysis

Company Overview

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

Key Stats

• Today's Range: $6.28 to $6.51
• 50-Day Range: $6.21 to $7.83
• 52-Week Range: $5.95 to $18.82
• Volume: 397,814 shs
• Average Volume: 726,714 shs
• Market Capitalization: $322.87 million
• P/E Ratio: N/A
• Dividend Yield: 3.70%
• Price Target: $6.88
• Consensus Rating: Hold

Nu Skin Enterprises Stock Analysis - MarketRank™

Nu Skin Enterprises scored higher than 61% of companies evaluated by MarketBeat, and ranked 89th out of 151 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Hold

Consensus Rating

Nu Skin Enterprises has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Nu Skin Enterprises has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 11.76%

Earnings Growth

Earnings for Nu Skin Enterprises are expected to grow by 11.76% in the coming year, from $0.68 to $0.76 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Nu Skin Enterprises is -3.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Nu Skin Enterprises is -3.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Nu Skin Enterprises has a P/B Ratio of 0.39. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.82% of the float of Nu Skin Enterprises has been sold short.

Short Interest Ratio / Days to Cover

Nu Skin Enterprises has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Nu Skin Enterprises has recently increased by 101.72%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Leadership

Nu Skin Enterprises is a leading dividend payer. It pays a dividend yield of 3.66%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Nu Skin Enterprises does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, Nu Skin Enterprises will have a dividend payout ratio of 31.58% next year. This indicates that Nu Skin Enterprises will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 1.4 / 5
• Environmental Score: -2.56

Percentage of Shares Shorted

4.82% of the float of Nu Skin Enterprises has been sold short.

Short Interest Ratio / Days to Cover

Nu Skin Enterprises has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Nu Skin Enterprises has recently increased by 101.72%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 1.1 / 5
• News Sentiment: N/A

News Sentiment

Nu Skin Enterprises has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Consumer Staples companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Nu Skin Enterprises this week, compared to 3 articles on an average week.

Search Interest

4 people have searched for NUS on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added Nu Skin Enterprises to their MarketBeat watchlist in the last 30 days. This is a decrease of -93% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Nu Skin Enterprises insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 1.70% of the stock of Nu Skin Enterprises is held by insiders.

Percentage Held by Institutions

82.84% of the stock of Nu Skin Enterprises is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

NUS Stock Analysis - Frequently Asked Questions

How have NUS shares performed this year?

Nu Skin Enterprises' stock was trading at $6.89 on January 1st, 2025. Since then, NUS shares have decreased by 5.7% and is now trading at $6.4950.
View the best growth stocks for 2025 here.

How were Nu Skin Enterprises' earnings last quarter?

Nu Skin Enterprises, Inc. (NYSE:NUS) released its earnings results on Thursday, November, 7th. The company reported $0.17 EPS for the quarter, missing analysts' consensus estimates of $0.20 by $0.03. The firm had revenue of $430.15 million for the quarter, compared to the consensus estimate of $444.10 million. Nu Skin Enterprises had a positive trailing twelve-month return on equity of 5.47% and a negative net margin of 5.81%.

Who are Nu Skin Enterprises' major shareholders?

Nu Skin Enterprises' top institutional investors include Bank of New York Mellon Corp (1.23%), Rhumbline Advisers (0.28%), Inspire Investing LLC (0.13%) and Y Intercept Hong Kong Ltd (0.13%). Insiders that own company stock include Ryan S Napierski, Steven Keith Hatchett, Mark H Lawrence, Andrew D Lipman, Joseph Y Chang, Steven Lund, Edwina D Woodbury, James D Thomas, Laura Nathanson and Emma S Battle.
View institutional ownership trends.

How do I buy shares of Nu Skin Enterprises?

Shares of NUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Nu Skin Enterprises own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Nu Skin Enterprises investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), Alphabet (GOOG) and Intel (INTC).

Company Calendar

• Last Earnings: 11/07/2024
• Ex-Dividend for 12/11 Dividend: 11/29/2024
• Dividend Payable: 12/11/2024
• Today: 2/04/2025
• Next Earnings (Estimated): 2/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Consumer Staples
• Industry: Drugs, proprietaries, & sundries
• Sub-Industry: Personal Products
• Current Symbol: NYSE:NUS
• CUSIP: 67018T10
• CIK: 1021561
• Web: www.nuskinenterprises.com
• Phone: (801) 345-1000
• Fax: 801-345-5999
• Employees: 3,700
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $6.88
• High Stock Price Target: $7.00
• Low Stock Price Target: $6.75
• Potential Upside/Downside: +5.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($2.07)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 9.55
• P/E Growth: N/A
• Net Income: $8.60 million
• Net Margins: -5.81%
• Pretax Margin: -6.08%
• Return on Equity: 5.47%
• Return on Assets: 2.46%

Debt

• Debt-to-Equity Ratio: 0.53
• Current Ratio: 1.93
• Quick Ratio: 1.20

Sales & Book Value

• Annual Sales: $1.97 billion
• Price / Sales: 0.16
• Cash Flow: $3.26 per share
• Price / Cash Flow: 1.99
• Book Value: $16.60 per share
• Price / Book: 0.39

Miscellaneous

• Outstanding Shares: 49,710,000
• Free Float: 48,866,000
• Market Cap: $322.87 million
• Optionable: Optionable
• Beta: 1.17